Transgene Supports Proposed Acquisition of Jennerex by SillaJen

27-11-2013 Business Wire HealthComments (0)

PharmaceuticalSillaJenTransgene

Regulatory News: Transgene SA (Paris:TNG) (NYSE-Euronext: TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has consequently given its consent to the definitive merger agreement. The agreement is subject to normal closing conditions and completion of financing by SillaJen. Including potential future milestone payments, total consideration for the all-cash transaction could reach approximately $

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top